MUFG Securities EMEA’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-10,000
Closed -$518K – 166
2022
Q1
$518K Hold
10,000
– – 0.01% 104
2021
Q4
$591K Hold
10,000
– – 0.01% 140
2021
Q3
$430K Buy
+10,000
New +$443K ﹤0.01% 248
2021
Q2
– Sell
-10,000
Closed -$362K – 391
2021
Q1
$362K Hold
10,000
– – ﹤0.01% 328
2020
Q4
$368K Sell
10,000
-540
-5% -$19.8K ﹤0.01% 348
2020
Q3
$367K Buy
+10,540
New +$370K ﹤0.01% 349
2020
Q2
– Sell
-1,054,000
Closed -$32.6M – 483
2020
Q1
$32.6M Hold
1,054,000
– – 0.33% 58
2019
Q4
$39.2M Hold
1,054,000
– – 0.31% 71
2019
Q3
$35.9M Buy
+1,054,000
New +$38.3M 0.43% 49
2019
Q2
– Sell
-10,540
Closed -$425K – 497
2019
Q1
$425K Hold
10,540
– – ﹤0.01% 441
2018
Q4
$437K Hold
10,540
– – ﹤0.01% 358
2018
Q3
$441K Buy
+10,540
New +$406K 0.01% 492

Other funds holding PFE

MUFG Securities EMEA's PFE Position: Q3 2026 in Review

MUFG Securities EMEA reduced its Pfizer (PFE) stake by 19% in Q3 2026, selling an estimated $1.15M and leaving 179,822 shares worth $5.13M. The position accounts for 0.05% of the portfolio, ranked #194.

MUFG Securities EMEA first reported a position in PFE in Q1 2014 and has held it in 37 quarters since. The position peaked at $114M in Q4 2017. 2,907 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • MUFG Securities EMEA held 179,822 shares of Pfizer worth $5.13M as of Q3 2026.
  • MUFG Securities EMEA sold 43,257 Pfizer shares in Q3 2026, an estimated $1.15M.
  • Pfizer made up 0.05% of MUFG Securities EMEA's portfolio in Q3 2026, its #194 holding.
  • MUFG Securities EMEA first reported a position in Pfizer in Q1 2014 and has held it in 37 quarters since.
  • MUFG Securities EMEA's Pfizer position peaked at $114M in Q4 2017.
  • 2,907 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on MUFG Securities EMEA's 13F filing for Q3 2026, filed 12 Nov 2026.